Screener
United Therapeutics UTHR Issuance of stock under employee stock plans
Issuance of stock under employee stock plans at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans.
The source filing: United Therapeutics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001082554-26-000020
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Payments to repurchase common stock | (1,500.0) | — |
| Repayment of line of credit | — | (100.0) |
| Proceeds from the exercise of stock options | 68.3 | 16.6 |
| Proceeds from the issuance of stock under ESPP | 5.6 | 4.9 |
| RSUs withheld for taxes | (58.3) | (15.3) |
| Net cash used in financing activities | (1,484.4) | (93.8) |
| Net (decrease) increase in cash and cash equivalents | $(277.4) | $202.7 |
| Cash and cash equivalents, beginning of period | 1,557.1 | 1,697.2 |
Item 1. Consolidated Financial Statements
FAQ
- What is United Therapeutics's issuance of stock under employee stock plans?
- United Therapeutics (UTHR) reported issuance of stock under employee stock plans of $5.6M in Q1 2026.
- How has United Therapeutics's issuance of stock under employee stock plans changed year-over-year?
- United Therapeutics's issuance of stock under employee stock plans increased by 14.3% year-over-year, from $4.9M to $5.6M.
- What does issuance of stock under employee stock plans mean?
- Issuance of stock under employee stock plans
Ask your AI about United Therapeutics's issuance of stock under employee stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude